Kidney graft success - does age and sex matter?
The success of kidney transplant is dependent on the age and sex of both the donor and the recipient, according to research published...
On the genetics trail
Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical...
Encouraging results for patients with aggressive brain cancer
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types...
A prescription with legs!
A study from the Research Institute of the McGill University Health Centre (RI-MUHC) shows that physician-delivered step count...
What is high Lipoprotein(a), and should I be concerned?
A team of researchers from the Research Institute of the McGill University Health Center (RI-MUHC) found that elevations in a unusual...
New marker and potential therapy for triple negative breast cancer
Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...
A surprise advance in the treatment of adult cancers
A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of...
New marker identified for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...
A race against time to diagnose deadly weight loss in cancer patients
About one third of cancer patients die because of cachexia – an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely...
A key to unlocking the mystery of triple negative breast cancer
A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor...